Skip to main content
Clinical Trials/NCT04924777
NCT04924777
Completed
N/A

Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus

Riphah International University1 site in 1 country48 target enrollmentApril 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 Diabetes Mellitus
Sponsor
Riphah International University
Enrollment
48
Locations
1
Primary Endpoint
HbA1c Levels
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.

Detailed Description

To the best of authors knowledge so far the studies have been conducted on different modes of moderate physical activity on glycemic control in type 2 diabetes, current study goal is to evaluate which mode of moderate physical activity has more significant result on glycemic control in type 2 diabetes and is sustainable in Pakistani society according to the socioeconomic status and cost effectiveness of the modes of moderate physical activity.

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
July 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants falling in this category would be recruited into the study.
  • Male/female
  • Diabetic type 2 patients
  • Age: 30-70 years
  • Overweight
  • Fat % in male\> 25
  • Fat % in female \>35
  • HbA1c level more than 48mmol/mol or \>6.5%
  • Fasting Plasma Glucose level \>126 mg/dl (7.0 mmol/l)
  • Random Plasma glucose level \>200 mg/dl (11.1 mmol/l)

Exclusion Criteria

  • Participant failing to fall in this category would be excluded of the study.
  • Type 1 diabetes
  • Insulin dependant type 2 diabetes
  • Gestational Diabetes
  • Hypertension
  • Cigarette smoking
  • Cardiovascular Disease
  • Cerebrovascular disease
  • Cardiopulmonary Disorders
  • Cognition Problems

Outcomes

Primary Outcomes

HbA1c Levels

Time Frame: 3 months

Reduction in HbA1c levels

Study Sites (1)

Loading locations...

Similar Trials